BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Anisomycin

An antibiotic isolated from various Streptomyces species. It interferes with protein and DNA synthesis by inhibiting peptidyl transferase or the 80S ribosome system.

247+ PubMed studies analyzed · Evidence Score: 39.1

Research Domains

Anisomycin has been studied across 24 research domains including 🏋️ Muscle & Hypertrophy, 🧠 Memory, 🔬 Oncology, 🧠 Learning, 🔬 Inflammation. The primary research focus is 🏋️ Muscle & Hypertrophy with 37% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Anisomycin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Strophanthidin
24 shared targets
Tubercidin
22 shared targets
cycloheximide
30 shared targets
Lanatosides
18 shared targets
Digoxigenin
20 shared targets
Digitoxigenin
19 shared targets
tyrphostin
22 shared targets
Digoxin
22 shared targets
Dinitrochlorobenzene
15 shared targets
Azacitidine
15 shared targets
Loading evidence profile...

This evidence profile for Anisomycin is generated deterministically from 247 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.